Mineralys Therapeutics, Inc. MLYS Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s change in other assets?
- Mineralys Therapeutics, Inc. (MLYS) reported change in other assets of $1.95M in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s change in other assets changed year-over-year?
- Mineralys Therapeutics, Inc.'s change in other assets decreased by 55.7% year-over-year, from $4.4M to $1.95M.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s change in other assets?
- Over 2 years (2022 to 2025), Mineralys Therapeutics, Inc.'s change in other assets has grown at a 5.0% compound annual growth rate (CAGR), from $2.24M to -$2.47M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.